Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
about
Effects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivoIncreased matrix metalloproteinase activation in esophageal squamous cell carcinomaSingle-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status.Areca nut chewing and esophageal squamous-cell carcinoma risk in Asians: a meta-analysis of case-control studies.Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinomaThe influence of matrix metalloproteinase-2, -9, and -12 promoter polymorphisms on Iranian patients with oesophageal squamous cell carcinomaAurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.XBP1 induces MMP-9 expression to promote proliferation and invasion in human esophageal squamous cell carcinoma.DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.Maximum standardized uptake value in (18)F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer.Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma.Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinomaUpregulated expression of MMP-9 in gingival epithelial cells induced by prolonged stimulation with arecoline.Epb41l3 suppresses esophageal squamous cell carcinoma invasion and inhibits MMP2 and MMP9 expression.Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus.Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling.High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma.Role of Brg1 in progression of esophageal squamous cell carcinoma.BMP7 expression in esophageal squamous cell carcinoma and its potential role in modulating metastasis.Effects of RNAi-mediated matrix metalloproteinase-2 gene silencing on the invasiveness and adhesion of esophageal carcinoma cells, KYSE150.Clinicopathological and prognostic role of MMP-9 in esophageal squamous cell carcinoma: a meta-analysis.Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation.Heat-induced inflammation and its role in esophageal cancer.Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma.Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway.Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis.Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
P2860
Q33598470-7F06DE85-467C-40F9-8B12-DE391C03082CQ33710260-967774F0-C88E-4693-AFF7-EF8A97DBC817Q33952599-369EC653-3970-40A4-B51E-44837820E4E2Q34258256-9F291E47-1380-4C88-A5C7-D3BF7E57CAC2Q34316553-196DF0C4-9541-44DB-81EC-EA91987F44EDQ34586333-8288F9E9-5BB2-45E4-9C3A-F2104DF9AA6AQ36243972-0C595762-F00C-4457-A450-A4147F85D9D6Q37020076-02074F99-F8FD-495B-A00C-F9FFAC796E1CQ37298310-66C76972-8DE2-4904-9FB8-2CE71BF2E1CFQ37362656-2AE4FCA4-0D77-471C-9A94-5BEB0356272BQ37567827-0AF529E7-CF58-457D-88C4-02501DB38115Q37577954-BEA20B60-655C-4F64-A915-23C6D75183A5Q37669487-0A22DE2C-C82F-4A18-B7B8-3489DD7456EEQ37687371-2CB0844B-6027-40BC-8C5D-FC69998BDD26Q37701605-CD9C202F-2302-440B-BB0D-4D058427EFD1Q38685993-07010C8B-7CE9-4207-8A9A-12F074F478AAQ38791022-807B275B-B82B-42B5-8237-92B071602432Q38794745-445DB7BB-84DE-4011-AE96-2D54D4EF6068Q38813473-876D1D8C-F9E6-4945-B6A2-9B95047BB879Q38874640-EB326548-7CCC-4B52-A4CF-C8C32B880C50Q38908465-D6EF7308-963E-480F-AC13-5CC795E4BE5EQ39179407-210F3875-DA83-41A8-8E43-72F17E0EC751Q39481861-3516846B-35C9-4C60-917D-7391B0D0E368Q42776399-F2D27DD7-9A58-46FA-9FEE-08526BDB6439Q43853392-27E0E379-3E89-4A5E-B275-08B0CDF6E06AQ47153289-A1C3ADA8-826C-4784-AD5F-838737926620Q48021632-CE393138-9BCC-4FAF-817B-9FAE7133AF49Q48350334-9059A0C1-25F7-4011-8311-E9DE322363E9Q49883610-14C2DDBC-C1CE-426C-931F-D36331460CD5Q53292464-DD718E16-CCF6-4161-A147-988F2E479411Q54281504-86A3F9EE-2369-4BD1-8C1F-EC342C21834F
P2860
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
@en
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
@nl
type
label
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
@en
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
@nl
prefLabel
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
@en
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
@nl
P2093
P1476
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
@en
P2093
Fangling Duan
Fu'ai Tang
Gaofeng Lu
Pengyuan Zheng
Zhiguo Zhao
P304
P356
10.1111/J.1442-2050.2008.00928.X
P577
2009-01-23T00:00:00Z